PerfAction has developed a new method for controlling the rate and quantity of anti-wrinkle treatments injected into the upper epidermis.
ProSeed Venture Capital Fund (TASE:PRSD) will invest $2 million in a financing round by PerfAction Technologies Ltd. The round will total $2-3 million altogether.
PerfAction has developed a new method for controlling the rate and quantity of anti-wrinkle treatments injected into the upper epidermis. The company says that its method instigates skin cell renewal, resulting in a younger look, and added that it already has sales. The company was founded by former Lumenis CEO Yacha Sutton, Radiancy co-founders Zion Ezer and Pinchas Shalev, and Eyal Bar-Or.
ProSeed CEO Niv Sarne said that the main reason the fund decided to invest in PerfAction was its experience entrepreneurial team. He added that ProSeed planned to play a more active role and lead financing rounds in companies.
Published by Globes [online], Israel business news - www.globes.co.il - on July 5, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007